Literature DB >> 8820423

Characterization of rat small intestinal cytochrome P450 composition and inducibility.

Q Y Zhang1, J Wikoff, D Dunbar, L Kaminsky.   

Abstract

The composition and inducibility of cytochrome P450 (P450) in rat small intestinal epithelial cells were investigated with the use of RNA-polymerase chain reaction and immunoblot techniques. The complement of intestinal P450s is more restricted than hepatic forms. P450s 1A1, 2B1, and 3A1 were detected in enterocytes of untreated rats and were inducible by beta-naphthoflavone (BNF), phenobarbital, and pregnenolone-16alpha-carbonitrile or dexamethasone, respectively. In addition, P450s 2C6 and 2C11 were both constitutively expressed at low levels. In contrast, several P450 forms, which are found in the liver, were not detected in enterocytes of untreated or induced rats, including P450s 2A1, 2B2, 2E1, 3A2, and 4A1. P4501A2 mRNA was detected only in BNF-induced rat small intestine and at levels that did not result in its detectable translation. The most prominent inducible form in rat small intestine is P4501A1. Its inducibility diminishes markedly along the length of the small intestine from the duodenum to the ileum. Furthermore, the induction of P4501A1 in enterocytes was affected by the route of administration of the inducing agent. Thus, intestinal P4501A1 was more sensitive to orally administered BNF, whereas induction of hepatic P4501A1 was more sensitive to intraperitoneal administered BNF. Overall, the results demonstrate the differential regulation of P450s between the liver and small intestine, and provide a basis for further studies in assessing the potential of intestinal P450s to protect against orally ingested polycyclic aromatic hydrocarbon carcinogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820423

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  12 in total

1.  Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures.

Authors:  K Mohri; Y Uesawa
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

2.  PEPT1 enhances the uptake of gabapentin via trans-stimulation of b0,+ exchange.

Authors:  Theresa V Nguyen; David E Smith; David Fleisher
Journal:  Pharm Res       Date:  2006-12-28       Impact factor: 4.200

3.  Intestinal permeability of metformin using single-pass intestinal perfusion in rats.

Authors:  Nai-Ning Song; Quan-Sheng Li; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

4.  Contribution of rat intestinal metabolism to the xenobiotics clearance.

Authors:  Mahmud Kajbaf; Raffaella Ricci; Serenella Zambon; Stefano Fontana
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-06-20       Impact factor: 2.441

5.  Intestinal absorption characteristics of imperialine: in vitro and in situ assessments.

Authors:  Qing Lin; Li-qin Ling; Ling Guo; Tao Gong; Xun Sun; Zhi-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2015-06-08       Impact factor: 6.150

6.  Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver.

Authors:  Monica Lindell; Matti Lang; Hans Lennernäs
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

7.  Metabolism of benzo(a)pyrene by subcellular fractions of gastrointestinal (GI) tract and liver in Apc(Min) mouse model of colon cancer.

Authors:  Jane A Mantey; Perumalla V Rekhadevi; Deacqunita L Diggs; Aramandla Ramesh
Journal:  Tumour Biol       Date:  2014-01-30

8.  Cancer in wildlife, a case study: beluga from the St. Lawrence estuary, Québec, Canada.

Authors:  Daniel Martineau; Karin Lemberger; André Dallaire; Philippe Labelle; Thomas P Lipscomb; Pascal Michel; Igor Mikaelian
Journal:  Environ Health Perspect       Date:  2002-03       Impact factor: 9.031

Review 9.  Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models.

Authors:  Sheila Annie Peters; Christopher R Jones; Anna-Lena Ungell; Oliver J D Hatley
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

10.  Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors.

Authors:  Oliver J D Hatley; Christopher R Jones; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  Biopharm Drug Dispos       Date:  2017-04       Impact factor: 1.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.